Citalopram, venlafaxine and mirtazapine judged on their merits: Treatment of neuropathic pain
R. Jurg, E. van Roon, Hans Koning, T. Bruinen
Abstract
R. Jurg, E. van Roon, Hans Koning, T. Bruinen
Abstract
The response of neuropathic pain on treatment with elassie analgesics is limited. As primary or adjuvant therapy treatment with tricyclic antidepressants and anti-epileptics can be iniated. Reports on the efficacy of newer antidepressant for neuropathic pain led to evaluation of the study results for citopram, venlafaxine and mirrazapine.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The response of neuropathic pain on treatment with elassie analgesics is limited. As primary or adjuvant therapy treatment with tricyclic antidepressants and anti-epileptics can be iniated. Reports on the efficacy of newer antidepressant for neuropathic pain led to evaluation of the study results for citopram, venlafaxine and mirrazapine.
Key concepts: Mirtazapine, Venlafaxine, Citalopram, Neuropathic pain, Venlafaxine Hydrochloride, Medicine, Mianserin, Anesthesia